Citigroup’s Zevra Therapeutics ZVRA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $204K | Sell |
21,930
-96,764
| -82% | -$872K | ﹤0.01% | 3998 |
|
|
2025
Q4 | $1.06M | Buy |
118,694
+101,172
| +577% | +$957K | ﹤0.01% | 3104 |
|
|
2025
Q3 | $167K | Sell |
17,522
-42,612
| -71% | -$427K | ﹤0.01% | 4064 |
|
|
2025
Q2 | $530K | Buy |
60,134
+16,013
| +36% | +$130K | ﹤0.01% | 3587 |
|
|
2025
Q1 | $330K | Sell |
44,121
-7,163
| -14% | -$56.9K | ﹤0.01% | 3897 |
|
|
2024
Q4 | $428K | Buy |
51,284
+20,753
| +68% | +$177K | ﹤0.01% | 3941 |
|
|
2024
Q3 | $212K | Buy |
30,531
+21,199
| +227% | +$144K | ﹤0.01% | 4298 |
|
|
2024
Q2 | $45.7K | Buy |
9,332
+2,279
| +32% | +$10.8K | ﹤0.01% | 4632 |
|
|
2024
Q1 | $40.9K | Buy |
7,053
+1,675
| +31% | +$10.3K | ﹤0.01% | 4719 |
|
|
2023
Q4 | $35.2K | Buy |
5,378
+5,360
| +29,778% | +$25.1K | ﹤0.01% | 4702 |
|
|
2023
Q3 | $87 | Sell |
18
-10,314
| -100% | -$51.5K | ﹤0.01% | 5440 |
|
|
2023
Q2 | $52.7K | Sell |
10,332
-48,164
| -82% | -$260K | ﹤0.01% | 4611 |
|
|
2023
Q1 | $322K | Sell |
58,496
-13,250
| -18% | -$70.1K | ﹤0.01% | 3451 |
|
|
2022
Q4 | $329K | Buy |
71,746
+67,717
| +1,681% | +$344K | ﹤0.01% | 3445 |
|
|
2022
Q3 | $25K | Buy |
4,029
+3,186
| +378% | +$18K | ﹤0.01% | 4662 |
|
|
2022
Q2 | $4K | Sell |
843
-1,293
| -61% | -$5.89K | ﹤0.01% | 5725 |
|
|
2022
Q1 | $11K | Sell |
2,136
-6,699
| -76% | -$42.6K | ﹤0.01% | 5492 |
|
|
2021
Q4 | $77K | Buy |
8,835
+5,578
| +171% | +$49.8K | ﹤0.01% | 4865 |
|
|
2021
Q3 | $30K | Buy |
3,257
+1,897
| +139% | +$19.1K | ﹤0.01% | 5036 |
|
|
2021
Q2 | $17K | Buy |
+1,360
| New | +$14.6K | ﹤0.01% | 5404 |
|
|
2016
Q4 | – | Sell |
-148
| Closed | -$11K | – | 7360 |
|
|
2016
Q3 | $11K | Buy |
148
+39
| +36% | +$2.77K | ﹤0.01% | 6507 |
|
|
2016
Q2 | $7K | Sell |
109
-5
| -4% | -$823 | ﹤0.01% | 6690 |
|
|
2016
Q1 | $26K | Sell |
114
-13
| -10% | -$3.15K | ﹤0.01% | 6439 |
|
|
2015
Q4 | $40K | Buy |
+127
| New | +$34.5K | ﹤0.01% | 6095 |
|
Other funds holding ZVRA
WP
NCM
VCM
ACM
